HF
HOWL icon

HRT Financial’s Werewolf Therapeutics HOWL Stock Holding History

HRT Financial’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
+17,861
New +$12.2K ﹤0.01% 3601
2025
Q4 		– Sell
-39,859
Closed -$78K – 3525
2025
Q3 		$78K Sell
39,859
-2,621
-6% -$3.59K ﹤0.01% 2549
2025
Q2 		$46K Buy
+42,480
New +$43.7K ﹤0.01% 2318
2024
Q3 		– Sell
-197,377
Closed -$481K – 2726
2024
Q2 		$481K Buy
197,377
+159,749
+425% +$767K ﹤0.01% 1317
2024
Q1 		$243K Buy
+37,628
New +$219K ﹤0.01% 1664

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's HOWL Position: Q1 2026 in Review

HRT Financial opened a new position in Werewolf Therapeutics (HOWL) in Q1 2026: 17,861 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #3601 among its holdings. This is a return to the name: HRT Financial previously reported a position in HOWL as recently as Q3 2025.

HRT Financial first reported a position in HOWL in Q1 2024 and has held it in 5 quarters since. The position peaked at $481K in Q2 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • HRT Financial held 17,861 shares of Werewolf Therapeutics worth $14K as of Q1 2026.
  • Werewolf Therapeutics was a new HRT Financial position in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3601 holding.
  • HRT Financial first reported a position in Werewolf Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • HRT Financial's Werewolf Therapeutics position peaked at $481K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.